Huize Holding（HUIZ）株式概要恵沢控股有限公司は、その子会社とともに、中国本土、香港、および国際的な様々なインターネット・チャネルを通じて、オンライン保険商品およびサービス・プラットフォームを提供している。 詳細HUIZ ファンダメンタル分析スノーフレーク・スコア評価1/6将来の成長3/6過去の実績3/6財務の健全性6/6配当金0/6報酬収益は年間47.85%増加すると予測されています 今年は黒字化を達成 リスク分析US市場と比較した過去 3 か月間の株価の変動意味のある時価総額がありません ( $18M )すべてのリスクチェックを見るHUIZ Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValueUS$Current PriceUS$1.478.1% 割高 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-108m2b2016201920222025202620282031Revenue CN¥2.2bEarnings CN¥5.6mAdvancedSet Fair ValueView all narrativesHuize Holding Limited 競合他社Marketing AllianceSymbol: OTCPK:MAALMarket cap: US$11.3mSelectQuoteSymbol: NYSE:SLQTMarket cap: US$176.3mWaterdropSymbol: NYSE:WDHMarket cap: US$517.4mCrawfordSymbol: NYSE:CRD.BMarket cap: US$505.1m価格と性能株価の高値、安値、推移の概要Huize Holding過去の株価現在の株価US$1.4752週高値US$4.5352週安値US$1.19ベータ0.881ヶ月の変化-11.98%3ヶ月変化-23.83%1年変化-26.50%3年間の変化-73.98%5年間の変化-95.41%IPOからの変化-97.06%最新ニュースValuation Update With 7 Day Price Move • May 20Investor sentiment improves as stock rises 20%After last week's 20% share price gain to US$1.80, the stock trades at a trailing P/E ratio of 30.6x. Average forward P/E is 11x in the Insurance industry in the US. Total loss to shareholders of 65% over the past three years.Board Change • May 20Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. Independent Director Bin Wei was the last director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.お知らせ • Mar 17Huize Holding Limited to Report Second Half, 2025 Results on Mar 27, 2026Huize Holding Limited announced that they will report second half, 2025 results on Mar 27, 2026分析記事 • Jan 01Huize Holding Limited's (NASDAQ:HUIZ) Prospects Need A Boost To Lift SharesWhen close to half the companies in the United States have price-to-earnings ratios (or "P/E's") above 19x, you may...お知らせ • Nov 27Huize Holding Limited, Annual General Meeting, Dec 17, 2025Huize Holding Limited, Annual General Meeting, Dec 17, 2025, at 10:00 China Standard Time. Location: suite 3904-3905, tower 6, the gateway, harbour city, tsim sha tsui, hong kong Chinaお知らせ • Oct 02Huize Holding Limited Announces Resignation of Mr. Aaron Xiaolei Hou as an Independent Director from the Board of Directors and as A Member of Each of the Nominating and Corporate Governance Committee, the Audit Committee and the Compensation Committee of the Board, Effective September 30, 2025Huize Holding Limited announced that Mr. Aaron Xiaolei Hou has tendered his resignation from his position as an independent director from the board of directors (the “Board”) and as a member of each of the nominating and corporate governance committee, the audit committee and the compensation committee of the Board, effective September 30, 2025, due to personal reasons. Mr. Hou's resignation did not result from any disagreement with the Company. The Board has resolved to appoint Mr. Cunjun Ma as the chairperson of the nominating and corporate governance committee of the Board, replacing Mr. Hou’s role.最新情報をもっと見るRecent updatesValuation Update With 7 Day Price Move • May 20Investor sentiment improves as stock rises 20%After last week's 20% share price gain to US$1.80, the stock trades at a trailing P/E ratio of 30.6x. Average forward P/E is 11x in the Insurance industry in the US. Total loss to shareholders of 65% over the past three years.Board Change • May 20Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. Independent Director Bin Wei was the last director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.お知らせ • Mar 17Huize Holding Limited to Report Second Half, 2025 Results on Mar 27, 2026Huize Holding Limited announced that they will report second half, 2025 results on Mar 27, 2026分析記事 • Jan 01Huize Holding Limited's (NASDAQ:HUIZ) Prospects Need A Boost To Lift SharesWhen close to half the companies in the United States have price-to-earnings ratios (or "P/E's") above 19x, you may...お知らせ • Nov 27Huize Holding Limited, Annual General Meeting, Dec 17, 2025Huize Holding Limited, Annual General Meeting, Dec 17, 2025, at 10:00 China Standard Time. Location: suite 3904-3905, tower 6, the gateway, harbour city, tsim sha tsui, hong kong Chinaお知らせ • Oct 02Huize Holding Limited Announces Resignation of Mr. Aaron Xiaolei Hou as an Independent Director from the Board of Directors and as A Member of Each of the Nominating and Corporate Governance Committee, the Audit Committee and the Compensation Committee of the Board, Effective September 30, 2025Huize Holding Limited announced that Mr. Aaron Xiaolei Hou has tendered his resignation from his position as an independent director from the board of directors (the “Board”) and as a member of each of the nominating and corporate governance committee, the audit committee and the compensation committee of the Board, effective September 30, 2025, due to personal reasons. Mr. Hou's resignation did not result from any disagreement with the Company. The Board has resolved to appoint Mr. Cunjun Ma as the chairperson of the nominating and corporate governance committee of the Board, replacing Mr. Hou’s role.分析記事 • Sep 13Huize Holding Limited (NASDAQ:HUIZ) Surges 63% Yet Its Low P/E Is No Reason For ExcitementHuize Holding Limited ( NASDAQ:HUIZ ) shares have continued their recent momentum with a 63% gain in the last month...お知らせ • Sep 02Huize Holding Limited to Report Q2, 2025 Results on Sep 12, 2025Huize Holding Limited announced that they will report Q2, 2025 results Pre-Market on Sep 12, 2025分析記事 • Jul 15Even With A 35% Surge, Cautious Investors Are Not Rewarding Huize Holding Limited's (NASDAQ:HUIZ) Performance CompletelyDespite an already strong run, Huize Holding Limited ( NASDAQ:HUIZ ) shares have been powering on, with a gain of 35...お知らせ • May 23Huize Holding Limited to Report Q1, 2025 Results on Jun 06, 2025Huize Holding Limited announced that they will report Q1, 2025 results Pre-Market on Jun 06, 2025分析記事 • May 11Further Upside For Huize Holding Limited (NASDAQ:HUIZ) Shares Could Introduce Price Risks After 30% BounceHuize Holding Limited ( NASDAQ:HUIZ ) shareholders are no doubt pleased to see that the share price has bounced 30% in...分析記事 • Mar 26Not Many Are Piling Into Huize Holding Limited (NASDAQ:HUIZ) Stock Yet As It Plummets 27%Huize Holding Limited ( NASDAQ:HUIZ ) shareholders won't be pleased to see that the share price has had a very rough...お知らせ • Mar 10Huize Holding Limited to Report Q4, 2024 Results on Mar 24, 2025Huize Holding Limited announced that they will report Q4, 2024 results Pre-Market on Mar 24, 2025お知らせ • Jan 16Huize Launches Customized Mid-Tier Medical Insurance Product “PrimeMed” in Partnership with CCIC and MSH CHINAHuize Holding Limited announced the launch of “PrimeMed”, a customized mid-tier medical insurance product, in collaboration with China Continent Property & Casualty Insurance Co. Ltd. (CCIC) and MSH CHINA Enterprise Services Co. Ltd. (MSH CHINA). Designed to provide scarce, high-cost medical resources such as specialized and international departments in public hospitals and designated private medical institutions, this new solution addresses the need for flexible and affordable insurance coverage. “PrimeMed”’s key features include: Flexible deductibles: three plan options are offered, including zero or low shared deductibles, making inpatient services across different medical institutions more accessible while streamlining enrollment and claims processing. Children’s coverage: allows parents to insure children under 18, expanding protection options for the family. Relative deductible scheme: enables compensation from other sources (such as public health insurance) to offset deductibles, improving the accessibility of benefits. Affordable premiums: annual premiums start from RMB958 for the primary age group, with options to add accident outpatient emergency coverage and receive family package discounts.お知らせ • Nov 29Huize Holding Limited to Report Q3, 2024 Results on Dec 10, 2024Huize Holding Limited announced that they will report Q3, 2024 results Pre-Market on Dec 10, 2024分析記事 • Nov 26Huize Holding Limited (NASDAQ:HUIZ) Looks Inexpensive After Falling 25% But Perhaps Not Attractive EnoughThe Huize Holding Limited ( NASDAQ:HUIZ ) share price has fared very poorly over the last month, falling by a...お知らせ • Nov 01Huize Holding Limited, Annual General Meeting, Nov 29, 2024Huize Holding Limited, Annual General Meeting, Nov 29, 2024, at 10:00 China Standard Time. Location: 3904-3905, tower 6, the gateway, harbour city, tsim sha tsui hong kong, China分析記事 • Sep 18Huize Holding Limited's (NASDAQ:HUIZ) 30% Dip In Price Shows Sentiment Is Matching RevenuesUnfortunately for some shareholders, the Huize Holding Limited ( NASDAQ:HUIZ ) share price has dived 30% in the last...お知らせ • Sep 17Huize Holding Limited to Report Q2, 2024 Results on Sep 25, 2024Huize Holding Limited announced that they will report Q2, 2024 results Pre-Market on Sep 25, 2024お知らせ • Jun 22Huize Holding Limited (NasdaqGM:HUIZ) agreed to acquire an unknown minority stake in Global Care Consulting Joint Stock Company from VinaCapital Ventures.Huize Holding Limited (NasdaqGM:HUIZ) agreed to acquire an unknown minority stake in Global Care Consulting Joint Stock Company from VinaCapital Ventures on June 20, 2024. Pursuant to purchase of existing shares and subscription of new shares, VinaCapital Ventures will receive partial consideration of newly issued class A common shares of Huize Holding Limited out of which 50% will be subject to a one-year lock-up period.分析記事 • Jun 13Huize Holding Limited (NASDAQ:HUIZ) Surges 25% Yet Its Low P/S Is No Reason For ExcitementDespite an already strong run, Huize Holding Limited ( NASDAQ:HUIZ ) shares have been powering on, with a gain of 25...お知らせ • May 18Huize Holding Limited to Report Q1, 2024 Results on May 23, 2024Huize Holding Limited announced that they will report Q1, 2024 results After-Market on May 23, 2024お知らせ • Apr 20Huize Holding Limited Partners with PICC Life Insurance Company Limited to Launch "I Wu You - Low-Threshold Edition" - A Customized Critical Illness Insurance ProductHuize Holding Limited announced that it has partnered with PICC Life Insurance Company Limited to launch "i Wu You - Low-Threshold Edition", the latest customized critical illness insurance product in the "i Wu You" series that offers a personalized solution with a relaxed health declaration process to customers. 'i Wu You - Low- Threshold Edition' differentiates itself with three key product offerings: i) flexible coverage for 28 severe and three mild illnesses, with a maximum of one claim for severe illnesses and three claims for mild illnesses and an option of lifetime coverage or up to age 70; ii) a relaxed health declaration process that is open to customers with a history of pre-existing conditions, hospitalization, and premium loading; and iii) a low eligibility threshold open to customers aged 30 to 65. The product also offers customers additional value-added services including multi-disciplinary consultation.お知らせ • Apr 17Huize Holding Limited Partners with Aviva-COFCO Life Insurance Co., Ltd. to Launch Fu Man Jia, a Customized Participating Whole Life Insurance ProductHuize Holding Limited announced that it has partnered with Aviva-COFCO Life Insurance Co. Ltd. to launch “Fu Man Jia”, a customized participating whole life insurance product. Fu Man Jia” stands out with three key features: i) stable value growth with long-term potential returns: a guaranteed return on a compound basis of 2.5% with additional non-guaranteed annual dividend; ii) low threshold with high dividend flexibility: policy available to customers from 30 days after birth to 70 years old, with options in receiving dividend payout, including cash payment, dividends on deposit, premium reduction, or purchasing paid-up additional insurance; and iii) enhanced flexibility with premium payment terms of single upfront payment or annual payments ranging from 3 years to 15 years.お知らせ • Apr 16Huize Partners with Ruihua Health Assurance Corporation to Launch "Darwin Critical Care No.9" - A Customized Critical Illness Insurance ProductHuize Holding Limited announced that it has partnered with Ruihua Health Assurance Corporation to launch “Darwin Critical Care No.9”, the latest customized critical illness insurance product in the “Darwin Critical Care” series, which was first launched in 2018.Reported Earnings • Mar 24Full year 2023 earnings released: EPS: CN¥1.40 (vs CN¥0.61 loss in FY 2022)Full year 2023 results: EPS: CN¥1.40 (up from CN¥0.61 loss in FY 2022). Revenue: CN¥1.20b (up 3.3% from FY 2022). Net income: CN¥70.2m (up CN¥101.4m from FY 2022). Profit margin: 5.9% (up from net loss in FY 2022). The move to profitability was primarily driven by lower expenses. Revenue is forecast to stay flat during the next 2 years compared to a 5.9% growth forecast for the Insurance industry in the US. Over the last 3 years on average, earnings per share has increased by 65% per year but the company’s share price has fallen by 58% per year, which means it is significantly lagging earnings.お知らせ • Mar 22Huize Holding Limited (NasdaqGM:HUIZ) announces an Equity Buyback for $5 million worth of its shares.Huize Holding Limited (NasdaqGM:HUIZ) announces a share repurchase program. Under the program, the company will repurchase up to $5 million worth of its class A common shares in the form of American depositary shares. The company expects to fund repurchases made under this program from its cash balance and cash generated from operations. The repurchase program will be valid for 12 months.お知らせ • Mar 08Huize Holding Limited to Report Q4, 2023 Results on Mar 20, 2024Huize Holding Limited announced that they will report Q4, 2023 results Pre-Market on Mar 20, 2024Board Change • Mar 02Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. Independent Director Aaron Xiaolei Hou was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.分析記事 • Feb 06Market Cool On Huize Holding Limited's (NASDAQ:HUIZ) Revenues Pushing Shares 26% LowerUnfortunately for some shareholders, the Huize Holding Limited ( NASDAQ:HUIZ ) share price has dived 26% in the last...New Risk • Jan 21New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of American stocks, typically moving 11% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 2.9% per year for the foreseeable future. Minor Risks Share price has been volatile over the past 3 months (11% average weekly change). Market cap is less than US$100m (US$35.8m market cap).お知らせ • Dec 15Huize Holding Limited Partners with PICC Life Insurance Company Limited to Launch "Darwin Critical Care No.8 - Advanced" - Customized Critical Illness Insurance ProductHuize Holding Limited announced that it has partnered with PICC Life Insurance Company Limited ("PICC Life") to launch "Darwin Critical Care No.8 - Advanced", the latest customized critical illness insurance product in the "Darwin Critical Care" series, first launched in 2018. 'Darwin Critical Care No. 8 - Advanced' provides extensive coverage for 120 critical, 20 moderate, and 40 mild illnesses, and is distinguished by five key product highlights: i) cost-effectiveness, with a minimum annual premium of RMB 65, providing a maximum of 1 claim for severe illnesses, 3 claims for moderate illnesses, and 5 claims for mild illnesses; ii) rapid protection, with first claim available in as few as 90 days; i) low eligibility threshold, open to a large variety of occupation including electricians, firefighters, sailors, riot police, etc. and a lenient health condition screening for consumers with specified pre-existing conditions; iv) a premium waiver benefit for mild-to-moderate illness; and v) optional benefits including supplemental medical care benefits and benefits of up to 120% of the original sum assured for severe malignant tumors and a premium waiver benefit for critical illness. The product also offers customers value-added services such as unlimited online doctor consultations.Reported Earnings • Nov 23Third quarter 2023 earnings released: EPS: CN¥0.41 (vs CN¥0.21 loss in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.41 (up from CN¥0.21 loss in 3Q 2022). Revenue: CN¥292.4m (down 17% from 3Q 2022). Net income: CN¥20.2m (up CN¥30.7m from 3Q 2022). Profit margin: 6.9% (up from net loss in 3Q 2022). The move to profitability was driven by lower expenses. Revenue is forecast to grow 16% p.a. on average during the next 2 years, compared to a 6.5% growth forecast for the Insurance industry in the US. Over the last 3 years on average, earnings per share has increased by 36% per year but the company’s share price has fallen by 50% per year, which means it is significantly lagging earnings.Valuation Update With 7 Day Price Move • Nov 18Investor sentiment improves as stock rises 32%After last week's 32% share price gain to US$1.12, the stock trades at a trailing P/E ratio of 13.9x. Average forward P/E is 11x in the Insurance industry in the US. Total loss to shareholders of 85% over the past three years.お知らせ • Nov 06Huize Holding Limited to Report Q3, 2023 Results on Nov 17, 2023Huize Holding Limited announced that they will report Q3, 2023 results Pre-Market on Nov 17, 2023お知らせ • Nov 01Huize Holding Limited, Annual General Meeting, Nov 30, 2023Huize Holding Limited, Annual General Meeting, Nov 30, 2023, at 10:00 China Standard Time. Location: 76/F, The Center, 99 Queen’s Road Central, Hong Kong Special Administrative Region of the People’s Republic of China Central (Hong Kong) Hong Kongお知らせ • Sep 28Huize Holding Limited Partners with Dingcheng Life to Launch "Xiao Tao Qi No.2" - A Customized Child Critical Illness Insurance ProductHuize Holding Limited announced that it has partnered with Dingcheng Life Insurance Company Ltd. (Dingcheng Life) to launch "Xiao Tao Qi No.2", the latest child critical illness insurance product offering in the "Xiao Tao Qi" series, which extends coverage to more illnesses and increases the hospitalization allowances for families seeking protection for their children. “Xiao Tao Qi No.2” provides extensive coverage for 190 severe, moderate and mild illnesses (compared to 183 for “Xiao Tao Qi No.1”). It is also distinguished by three key product highlights: (i) for diseases other than those specified in the policy contract as severe, moderate, and mild illnesses, ICU hospital cash benefits of RMB 1,000 per day (starting from the second day of hospitalization) for up to 90 hospitalization days per policy year and 30% of the insured amount; (ii) hospital cash benefits of RMB 300 per day for up to 60 hospitalization days per policy year and 300 hospitalization days in policy lifetime for accidents or diseases suffered by policy beneficiaries in the aftermath of a diagnosed critical illness; (iii) six optional benefits, including first-time illness care benefits, hospitalization benefits after critical illness, multiple benefits for critical illness, severely extended malignant tumors benefits, family care benefits, and death and total disability benefits. The upgraded product also provides customers with value-added services such as online doctor consultations.Reported Earnings • Aug 17Second quarter 2023 earnings released: EPS: CN¥0.28 (vs CN¥0.77 loss in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.28 (up from CN¥0.77 loss in 2Q 2022). Revenue: CN¥368.2m (up 48% from 2Q 2022). Net income: CN¥14.1m (up CN¥53.5m from 2Q 2022). Profit margin: 3.8% (up from net loss in 2Q 2022). Revenue is forecast to grow 22% p.a. on average during the next 2 years, compared to a 5.2% growth forecast for the Insurance industry in the US. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has fallen by 49% per year, which means it is significantly lagging earnings.Breakeven Date Change • Aug 16Forecast to breakeven in 2023The 2 analysts covering Huize Holding expect the company to break even for the first time. New consensus forecast suggests the company will make a profit of CN¥44.0m in 2023. Earnings growth of 100% is required to achieve expected profit on schedule.お知らせ • Aug 04Huize Holding Limited to Report Q2, 2023 Results on Aug 15, 2023Huize Holding Limited announced that they will report Q2, 2023 results Pre-Market on Aug 15, 2023分析記事 • Jul 29Potential Upside For Huize Holding Limited (NASDAQ:HUIZ) Not Without RiskHuize Holding Limited's ( NASDAQ:HUIZ ) price-to-sales (or "P/S") ratio of 0.4x may look like a pretty appealing...Reported Earnings • Jun 02First quarter 2023 earnings released: EPS: CN¥0.35 (vs CN¥0.21 in 1Q 2022)First quarter 2023 results: EPS: CN¥0.35 (up from CN¥0.21 in 1Q 2022). Revenue: CN¥298.9m (flat on 1Q 2022). Net income: CN¥17.9m (up 70% from 1Q 2022). Profit margin: 6.0% (up from 3.5% in 1Q 2022). Revenue is forecast to grow 24% p.a. on average during the next 2 years, compared to a 6.1% growth forecast for the Insurance industry in the US. Over the last 3 years on average, earnings per share has fallen by 3% per year but the company’s share price has fallen by 45% per year, which means it is performing significantly worse than earnings.お知らせ • May 20Huize Holding Limited to Report Q1, 2023 Results on May 30, 2023Huize Holding Limited announced that they will report Q1, 2023 results at 9:30 AM, US Eastern Standard Time on May 30, 2023Reported Earnings • Mar 31Full year 2022 earnings released: CN¥0.61 loss per share (vs CN¥2.11 loss in FY 2021)Full year 2022 results: CN¥0.61 loss per share (improved from CN¥2.11 loss in FY 2021). Revenue: CN¥1.16b (down 48% from FY 2021). Net loss: CN¥31.2m (loss narrowed 71% from FY 2021). Revenue is forecast to grow 39% p.a. on average during the next 2 years, compared to a 5.5% growth forecast for the Insurance industry in the US. Over the last 3 years on average, earnings per share has fallen by 11% per year but the company’s share price has fallen by 42% per year, which means it is performing significantly worse than earnings.お知らせ • Dec 15Huize Regains Compliance with Nasdaq Minimum Bid Price RequirementHuize Holding Limited announced that it has received a notification letter (the "Compliance Notice") from the Listing Qualifications Department of the Nasdaq Stock Market Inc. ("Nasdaq") dated December 13, 2022, informing the Company that it has regained compliance with Nasdaq Listing Rule 5450(a)(1) (the "Minimum Bid Price Requirement"). As previously announced, the Company was notified by Nasdaq on October 12, 2022, that the Company was not in compliance with the Minimum Bid Price Requirement, as the closing bid price of the Company's American depositary shares ("ADSs") was below $1.00 per share for 30 consecutive business days. On December 13, 2022, Nasdaq confirmed in the Compliance Notice that the closing bid price of the Company's ADSs has been at $1.00 per share or greater for 11 consecutive business days from November 28, 2022, through December 12, 2022. According to the Compliance Notice, the Company has regained compliance with Listing Rule 5450(a)(1), and the matter is closed.Breakeven Date Change • Nov 19Forecast breakeven date pushed back to 2023The 2 analysts covering Huize Holding previously expected the company to break even in 2022. New consensus forecast suggests losses will reduce by 94% to 2022. The company is expected to make a profit of CN¥21.9m in 2023. Average annual earnings growth of 124% is required to achieve expected profit on schedule.Reported Earnings • Nov 18Third quarter 2022 earnings released: CN¥0.21 loss per share (vs CN¥1.55 loss in 3Q 2021)Third quarter 2022 results: CN¥0.21 loss per share (improved from CN¥1.55 loss in 3Q 2021). Revenue: CN¥351.8m (up 12% from 3Q 2021). Net loss: CN¥10.5m (loss narrowed 87% from 3Q 2021). Revenue is forecast to grow 29% p.a. on average during the next 3 years, compared to a 5.4% growth forecast for the Insurance industry in the US.お知らせ • Nov 12Huize Holding Limited Provides Earnings Guidance for the Final Quarter of 2022Huize Holding Limited provided earnings guidance for the final quarter of 2022. Based on the Company’s preliminary assessment of the current market conditions, the Company expects to achieve profitability in the final quarter of 2022. This forecast reflects the Company’s current and preliminary views on the market and operational conditions, which are subject to change as a result of various market uncertainties.お知らせ • Nov 04Huize Holding Limited to Report Q3, 2022 Results on Nov 11, 2022Huize Holding Limited announced that they will report Q3, 2022 results at 4:00 PM, US Eastern Standard Time on Nov 11, 2022お知らせ • Nov 03Huize Holding Limited, Annual General Meeting, Dec 01, 2022Huize Holding Limited, Annual General Meeting, Dec 01, 2022, at 10:00 China Standard Time. Location: 49/F, Building T1, Qianhai Financial Centre Qianhai,Shenzhen-Hong Kong Cooperation Zone, Shenzhen 518000 Shenzhen Chinaお知らせ • Oct 22Huize Partners with Guolian Life Insurance to Launch “Darwin Critical Care No. 7”Huize Holding Limited announced that it has partnered with Guolian Life Insurance Co. Ltd. (“Guolian Life Insurance”) to launch “Darwin Critical Care No. 7”, the latest critical illness insurance product offering in the Darwin Critical Care series, which offers additional benefits for severe/mild malignant tumors and carcinoma in situ, as well as ICU hospitalization benefits covering major diseases outside the list of severe, moderate and mild illnesses. “Darwin Critical Care No.7” policyholders will also be able to take advantage of Huize’s proprietary “Xiao Ma Claim” services. “Darwin Critical Care No. 7” is distinguished by five key product highlights: (i) extensive coverage for 110 critical, 35 moderate, and 40 mild illnesses, with a maximum of 8 claims; (ii) two additional benefits, with one for severe malignant tumors of up to 120% of the insured amount and another for mild malignant tumors and carcinoma in situ of up to 30% of the insured amount; (iii) additional ICU hospitalization benefits of up to 30% of the insured amount for 7 consecutive days of ICU hospitalization caused by major diseases other than those specified in the policy contract, such as shock, cardiac arrest and hypertensive crisis; (iv) cost-effective upgrade options for critical illness protections, such as the optional extension of coverage up to age 70; (v) other optional benefits including death and total disability benefits, family care benefits for critical illnesses before the age of 60, supplemental coverage for major illnesses such as specific cardiovascular diseases, malignant tumors or carcinoma in situ before the age of 60, and additional ICU hospitalization benefits.Seeking Alpha • Oct 14Huize gets non-compliance notice from NasdaqHuize (NASDAQ:HUIZ) said Friday it received a notice from Nasdaq indicating that it was not in compliance with the minimum bid price rule for continued listing. HUIZ has 180 days, or till Apr. 10, to regain compliance. If HUIZ does not regain compliance by then, it may be eligible for an additional 180-day compliance period if it meets other continued listing rules. In this case, HUIZ should provide written notice of its intention to cure the deficiency during the second compliance period, including by effecting a reverse stock split. HUIZ is at high risk of performing badly, according to SA Quant rating system, as it has decelerating momentum and inferior profitability vs. other financial stocks.Reported Earnings • Sep 26Second quarter 2022 earnings releasedSecond quarter 2022 results: Revenue: CN¥248.2m (up 14% from 2Q 2021). Net loss: CN¥39.4m (loss narrowed 49% from 2Q 2021). Revenue is forecast to grow 27% p.a. on average during the next 3 years, compared to a 5.2% growth forecast for the Insurance industry in the US.Seeking Alpha • Sep 23Huize Holding GAAP EPS of -$0.01, revenue of $37.06MHuize Holding press release (NASDAQ:HUIZ): Q2 GAAP EPS of -$0.01. Revenue of $37.06M (+13.5% Y/Y). Based on the company’s preliminary assessment of the current market conditions, the Company currently expects to achieve quarterly profitability in the second half of 2022.お知らせ • Sep 10Huize Holding Limited to Report Q2, 2022 Results on Sep 23, 2022Huize Holding Limited announced that they will report Q2, 2022 results at 9:30 AM, US Eastern Standard Time on Sep 23, 2022Reported Earnings • Jun 29First quarter 2022 earnings released: EPS: CN¥0.21 (vs CN¥0.56 in 1Q 2021)First quarter 2022 results: EPS: CN¥0.21 (down from CN¥0.56 in 1Q 2021). Revenue: CN¥299.5m (down 59% from 1Q 2021). Net income: CN¥10.6m (down 63% from 1Q 2021). Profit margin: 3.5% (down from 3.9% in 1Q 2021). The decrease in margin was driven by lower revenue. Over the next year, revenue is forecast to grow 24% while the industry in the US is not expected to grow.お知らせ • Jun 25Huize Holding Limited Provide Profit Guidance Second Half of 2022Huize Holding Limited provided profit guidance second half of 2022. Based on the Company's preliminary assessment of the current market conditions, the Company currently expects toachieve quarterly profitability in the second half of 2022. This forecast reflects the Company's current and preliminary views on the market and operational conditions, which are subject to change as a result of various market uncertainties.お知らせ • Jun 21Huize Holding Limited to Report Q1, 2022 Results on Jun 24, 2022Huize Holding Limited announced that they will report Q1, 2022 results Pre-Market on Jun 24, 2022Reported Earnings • May 02Full year 2021 earnings: EPS and revenues exceed analyst expectationsFull year 2021 results: CN¥2.11 loss per share (down from CN¥0.45 loss in FY 2020). Revenue: CN¥2.25b (up 84% from FY 2020). Net loss: CN¥107.7m (loss widened 401% from FY 2020). Revenue exceeded analyst estimates by 15%. Earnings per share (EPS) also surpassed analyst estimates by 72%. Over the next year, revenue is forecast to grow 24% while the insurance industry in the US is not expected to grow.Breakeven Date Change • Apr 27Forecast breakeven date pushed back to 2023The 2 analysts covering Huize Holding previously expected the company to break even in 2022. New consensus forecast suggests losses will reduce by 56% to 2022. The company is expected to make a profit of CN¥38.8m in 2023. Average annual earnings growth of 99% is required to achieve expected profit on schedule.お知らせ • Dec 18Huize Holding Limited (NasdaqGM:HUIZ) entered into an agreement to acquire Shanghai Senhao Insurance Agency Co., Ltd. for CNY 29.8 million.Huize Holding Limited (NasdaqGM:HUIZ) entered into an agreement to acquire Shanghai Senhao Insurance Agency Co., Ltd. for CNY 29.8 million on December 17, 2021. Transaction is subject to the satisfaction of customary conditions precedent. Transaction is expected to complete in the first quarter of 2022.分析記事 • Dec 09Broker Revenue Forecasts For Huize Holding Limited (NASDAQ:HUIZ) Are Surging HigherShareholders in Huize Holding Limited ( NASDAQ:HUIZ ) may be thrilled to learn that the analysts have just delivered a...Reported Earnings • Dec 04Third quarter 2021 earnings: EPS in line with analyst expectations despite revenue beatThird quarter 2021 results: CN¥1.55 loss per share (down from CN¥0.29 profit in 3Q 2020). Revenue: CN¥315.1m (down 9.6% from 3Q 2020). Net loss: CN¥78.9m (down CN¥93.6m from profit in 3Q 2020). Revenue exceeded analyst estimates by 2.5%. Over the next year, revenue is forecast to grow 55% compared to a 1.0% decline forecast for the industry in the US.Seeking Alpha • Dec 03Huize's Q3-21 Results, And Its Risks And OpportunitiesHUIZ released Q3-21 financial results, Gross Written Premiums (“GWP”) +24% YoY, and First-year premiums (“FYP”) +42.7% YoY. HUIZ is traded at 1.1x P/B and 0.27x P/S, clearly undervalued, but hard to predict its timing to recover. HUIZ could fare well for the industry regulatory changes as a 15-year veteran but still face the market "fear" along with other China stocks. HUIZ's market position seems more opportunities than risks.お知らせ • Dec 03Huize Holding Limited Provides Earnings Outlook for the Full Year of 2021Huize Holding Limited provided earnings outlook for the full year of 2021. For the period the company expect total operating revenue to be in the range of RMB 1.9 billion to RMB 2.0 billion, or approximately USD 295 to USD 310 million, an increase of approximately 56% to 64% year-over-year.Seeking Alpha • Nov 24Huize Grows Top Line But With Higher CostsChina-based Huize Holding went public in the U.S. in May 2020, raising $55 million. The firm provides an online marketplace for Chinese consumers to purchase various insurance and savings products. While HUIZ has grown revenue, operating costs have also risen and the firm faces ongoing regulatory risks domestically and in the U.S. At around $1.68 per share, my outlook on the stock is Neutral until these risks are materially reduced.Seeking Alpha • Sep 17Huize: Fundamentals Remain Intact, Undervalued With The Recent Sell-OffHUIZ's fundamentals remain intact, H1 2021 total gross written premium was RMB2.06, +72.7% YoY, and total operating revenue was RMB950 million, which nearly doubled YoY. HUIZ is traded at its all-time low of $2.18 vs. $13.85 52-week-high. This is about 0.5x TTM P/S, vs. SelectQuote's 2.5x TTM P/S. HUIZ is undervalued, especially with the recent selloff.Breakeven Date Change • Sep 15Forecast to breakeven in 2021The 4 analysts covering Huize Holding expect the company to break even for the first time. New consensus forecast suggests the company will make a profit of CN¥23.0m in 2021. Earnings growth of 160% is required to achieve expected profit on schedule.Breakeven Date Change • Sep 12Forecast to breakeven in 2021The 4 analysts covering Huize Holding expect the company to break even for the first time. New consensus forecast suggests the company will make a profit of CN¥77.0m in 2021. Earnings growth of 133% is required to achieve expected profit on schedule.Reported Earnings • Sep 12Second quarter 2021 earnings released: CN¥1.51 loss per share (vs CN¥0.073 loss in 2Q 2020)The company reported a poor second quarter result with increased losses, weaker revenues and weaker control over costs. Second quarter 2021 results: Revenue: CN¥218.6m (down 7.0% from 2Q 2020). Net loss: CN¥77.2m (loss widened CN¥73.5m from 2Q 2020).Valuation Update With 7 Day Price Move • Sep 10Investor sentiment deteriorated over the past weekAfter last week's 20% share price decline to US$2.38, the stock trades at a forward P/E ratio of 6x. Average forward P/E is 12x in the Insurance industry in the US. Total loss to shareholders of 72% over the past year.Seeking Alpha • Aug 31Huize Vs. SelectQuote: Which Is A Better InvestmentHuize and SelectQuote are online B2B2C insurance brokerages. Although it is significantly oversold lately, Huize continues to operate superior to its peers. Huize has bigger market share in a faster growing market.お知らせ • Aug 25Huize Holding Limited entered into a binding memorandum of agreement to acquire an unknown majority stake in Hubei Shengs Life & General Insurance Agency Co., Ltd.Huize Holding Limited entered into a binding memorandum of agreement to acquire an unknown majority stake in Hubei Shengs Life & General Insurance Agency Co., Ltd on August 24, 2021. Huize Holding Limited (NasdaqGM:HUIZ) will enter into definitive agreements with Shengs Life & General and its shareholders in connection with the transaction. Following the completion of the transaction, Shengs Life & General will be accounted for as a consolidated subsidiary of the Huize Holding Limited. Transaction is subject to completion of customary conditions. Huize Holding Limited expects the transaction to completed by the end of 2021Seeking Alpha • Aug 19Huize: The Dip Of The DecadeHuize is down 83% from its all-time high, and 78% from its IPO. The company has a huge upside because of its low valuation. Despite the massive selloff, Huize continues to grow & make its business consumer-friendly. It's highly likely that Huize will be the best-performing China stock of the 2020s.Valuation Update With 7 Day Price Move • Aug 13Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to CN¥2.70, the stock trades at a forward P/E ratio of 6x. Average forward P/E is 12x in the Insurance industry in the US. Total loss to shareholders of 69% over the past year.Reported Earnings • May 22First quarter 2021 earnings released: EPS CN¥0.56 (vs CN¥0.21 loss in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: CN¥735.0m (up 196% from 1Q 2020). Net income: CN¥28.5m (up CN¥34.0m from 1Q 2020). Profit margin: 3.9% (up from net loss in 1Q 2020). The move to profitability was driven by higher revenue.お知らせ • May 19Huize Holding Limited Provides Earnings Guidance for the Second Quarter of 2021Huize Holding Limited provided earnings guidance for the second quarter of 2021. The company currently expects total operating revenue for the second quarter of 2021 to be in the range of RMB 230 million to RMB 250 million. This forecast reflects the company’s current and preliminary views on the market and operational conditions, which are subject to change as a result of various market uncertainties, including those related to the ongoing COVID-19 pandemic globally.Reported Earnings • Mar 13Full year 2020 earnings releasedThe company reported a solid full year result with reduced losses, improved revenues and improved control over expenses. Full year 2020 results: Revenue: CN¥1.22b (up 23% from FY 2019). Net loss: CN¥23.6m (loss narrowed 6.9% from FY 2019).お知らせ • Mar 05Huize Holding Limited to Report Q4, 2020 Results on Mar 10, 2021Huize Holding Limited announced that they will report Q4, 2020 results Pre-Market on Mar 10, 2021Is New 90 Day High Low • Feb 11New 90-day high: US$8.15The company is up 11% from its price of US$7.37 on 12 November 2020. The American market is up 16% over the last 90 days, indicating the company underperformed over that time. However, its price trend is similar to the Insurance industry, which is also up 11% over the same period.お知らせ • Feb 10Huize Holding Limited Announces Changes to Board of DirectorsHuize Holding Limited announced the appointment of Mr. Aaron Xiaolei Hou to the company's board of directors, effective on February 12, 2021. Mr. Hou will also serve as a member of the audit committee of the board, a member of the compensation committee of the board, and a member of the nominating and corporate governance committee of the board. Mr. Li Jiang, the Company’s Chief Operating Officer, will step down from his position as a director of the Company, effective from the same date, following which the majority of the company's board will be comprised of independent directors. Mr. Jiang will continue to serve as the Chief Operating Officer of the Company. Mr. Hou has nearly 20 years of risk management and capital markets experience. He founded China Springs Capital Co. Ltd. in October 2016, and currently serves as its Chief Executive Officer and Chief Investment Officer.お知らせ • Jan 28Huize Holding Limited Announces Earnings Guidance for the Fourth Quarter of 2020Huize Holding Limited announced earnings guidance for the fourth quarter of 2020. Total operating revenue for the fourth quarter of 2020 is expected to be at least RMB 380 million, representing a record quarterly high and a year-over-year growth of 47.1%, exceeding the Company's previous guidance of RMB 330 million to RMB 350 million.Is New 90 Day High Low • Jan 20New 90-day low: US$6.60The company is down 10.0% from its price of US$7.33 on 21 October 2020. The American market is up 13% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Insurance industry, which is up 16% over the same period.Is New 90 Day High Low • Dec 24New 90-day low: US$6.95The company is down 12% from its price of US$7.93 on 24 September 2020. The American market is up 18% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Insurance industry, which is up 19% over the same period.分析記事 • Dec 08What Type Of Shareholders Own The Most Number of Huize Holding Limited (NASDAQ:HUIZ) Shares?Every investor in Huize Holding Limited ( NASDAQ:HUIZ ) should be aware of the most powerful shareholder groups...Reported Earnings • Nov 22Third quarter 2020 earnings released: EPS CN¥0.29The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2020 results: Revenue: CN¥348.5m (up 23% from 3Q 2019). Net income: CN¥14.7m (up CN¥14.4m from 3Q 2019). Profit margin: 4.2% (up from 0.1% in 3Q 2019). The increase in margin was driven by higher revenue.お知らせ • Nov 10Huize Holding Limited to Report Q3, 2020 Results on Nov 19, 2020Huize Holding Limited announced that they will report Q3, 2020 results at 9:00 AM, China Standard Time on Nov 19, 2020お知らせ • Nov 03Huize Holding Limited, Annual General Meeting, Dec 10, 2020Huize Holding Limited, Annual General Meeting, Dec 10, 2020, at 10:00 China Standard Time. Location: 5/F, Building 3-4, Shenzhen Animation Park, Yuehai Road Nanhai Avenue, Nanshan District Shenzhen China Agenda: To discuss Company affairs with management team.Is New 90 Day High Low • Oct 30New 90-day low: US$7.19The company is down 20% from its price of US$9.00 on 31 July 2020. The American market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Insurance industry, which is down 3.0% over the same period.Is New 90 Day High Low • Oct 10New 90-day low: US$7.88The company is down 17% from its price of US$9.50 on 10 July 2020. The American market is up 10.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Insurance industry, which is up 7.0% over the same period.お知らせ • Aug 13Huize Holding Limited to Report Q2, 2020 Results on Aug 20, 2020Huize Holding Limited announced that they will report Q2, 2020 results at 9:00 AM, China Standard Time on Aug 20, 2020株主還元HUIZUS InsuranceUS 市場7D-16.9%-0.7%2.5%1Y-26.5%-8.8%26.4%株主還元を見る業界別リターン: HUIZ過去 1 年間で-8.8 % の収益を上げたUS Insurance業界を下回りました。リターン対市場: HUIZは、過去 1 年間で26.4 % のリターンを上げたUS市場を下回りました。価格変動Is HUIZ's price volatile compared to industry and market?HUIZ volatilityHUIZ Average Weekly Movement13.4%Insurance Industry Average Movement4.4%Market Average Movement7.2%10% most volatile stocks in US Market16.5%10% least volatile stocks in US Market3.1%安定した株価: HUIZの株価は、 US市場と比較して過去 3 か月間で変動しています。時間の経過による変動: HUIZの weekly volatility ( 13% ) は過去 1 年間安定していますが、依然としてUSの株式の 75% よりも高くなっています。会社概要設立従業員CEO（最高経営責任者ウェブサイト2006853Cunjun Mahuize.com恵沢控股有限公司は、その子会社とともに、中国本土、香港、および国際的な様々なインターネット・チャネルを通じて、オンライン保険商品およびサービス・プラットフォームを提供している。生命保険、医療保険、疾病保険、年金保険、定期保険、終身保険、損害保険、旅行保険、個人賠償責任保険、企業賠償責任保険、商業財産保険、貨物保険（物流賠償責任保険、国際貨物運送人賠償責任保険、国際貨物船荷証券賠償責任保険）などを提供している。また、オフラインでの保険仲介・斡旋・代理店サービス、デジタル・テクノロジー開発サービス、投資・投資コンサルティングサービスも提供している。同社はまた、デジタル・テクノロジー開発サービス、投資コンサルティングサービス、保険代理店サービスも提供している。華澤控股有限公司は2006年に設立され、中国の深圳に本社を置く。もっと見るHuize Holding Limited 基礎のまとめHuize Holding の収益と売上を時価総額と比較するとどうか。HUIZ 基礎統計学時価総額US$17.69m収益（TTM）US$595.39k売上高(TTM)US$233.12m25.0xPER（株価収益率0.1xP/SレシオHUIZ は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計HUIZ 損益計算書（TTM）収益CN¥1.58b売上原価CN¥1.15b売上総利益CN¥428.36mその他の費用CN¥424.32m収益CN¥4.04m直近の収益報告Dec 31, 2025次回決算日該当なし一株当たり利益（EPS）0.40グロス・マージン27.07%純利益率0.26%有利子負債／自己資本比率13.9%HUIZ の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/26 08:21終値2026/05/26 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Huize Holding Limited 1 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。10 アナリスト機関Yuping MaCitigroup IncZhaohua WangEverbright Securities Co. Ltd.Yifeng WangEverbright Securities Co. Ltd.7 その他のアナリストを表示
Valuation Update With 7 Day Price Move • May 20Investor sentiment improves as stock rises 20%After last week's 20% share price gain to US$1.80, the stock trades at a trailing P/E ratio of 30.6x. Average forward P/E is 11x in the Insurance industry in the US. Total loss to shareholders of 65% over the past three years.
Board Change • May 20Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. Independent Director Bin Wei was the last director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.
お知らせ • Mar 17Huize Holding Limited to Report Second Half, 2025 Results on Mar 27, 2026Huize Holding Limited announced that they will report second half, 2025 results on Mar 27, 2026
分析記事 • Jan 01Huize Holding Limited's (NASDAQ:HUIZ) Prospects Need A Boost To Lift SharesWhen close to half the companies in the United States have price-to-earnings ratios (or "P/E's") above 19x, you may...
お知らせ • Nov 27Huize Holding Limited, Annual General Meeting, Dec 17, 2025Huize Holding Limited, Annual General Meeting, Dec 17, 2025, at 10:00 China Standard Time. Location: suite 3904-3905, tower 6, the gateway, harbour city, tsim sha tsui, hong kong China
お知らせ • Oct 02Huize Holding Limited Announces Resignation of Mr. Aaron Xiaolei Hou as an Independent Director from the Board of Directors and as A Member of Each of the Nominating and Corporate Governance Committee, the Audit Committee and the Compensation Committee of the Board, Effective September 30, 2025Huize Holding Limited announced that Mr. Aaron Xiaolei Hou has tendered his resignation from his position as an independent director from the board of directors (the “Board”) and as a member of each of the nominating and corporate governance committee, the audit committee and the compensation committee of the Board, effective September 30, 2025, due to personal reasons. Mr. Hou's resignation did not result from any disagreement with the Company. The Board has resolved to appoint Mr. Cunjun Ma as the chairperson of the nominating and corporate governance committee of the Board, replacing Mr. Hou’s role.
Valuation Update With 7 Day Price Move • May 20Investor sentiment improves as stock rises 20%After last week's 20% share price gain to US$1.80, the stock trades at a trailing P/E ratio of 30.6x. Average forward P/E is 11x in the Insurance industry in the US. Total loss to shareholders of 65% over the past three years.
Board Change • May 20Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. Independent Director Bin Wei was the last director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.
お知らせ • Mar 17Huize Holding Limited to Report Second Half, 2025 Results on Mar 27, 2026Huize Holding Limited announced that they will report second half, 2025 results on Mar 27, 2026
分析記事 • Jan 01Huize Holding Limited's (NASDAQ:HUIZ) Prospects Need A Boost To Lift SharesWhen close to half the companies in the United States have price-to-earnings ratios (or "P/E's") above 19x, you may...
お知らせ • Nov 27Huize Holding Limited, Annual General Meeting, Dec 17, 2025Huize Holding Limited, Annual General Meeting, Dec 17, 2025, at 10:00 China Standard Time. Location: suite 3904-3905, tower 6, the gateway, harbour city, tsim sha tsui, hong kong China
お知らせ • Oct 02Huize Holding Limited Announces Resignation of Mr. Aaron Xiaolei Hou as an Independent Director from the Board of Directors and as A Member of Each of the Nominating and Corporate Governance Committee, the Audit Committee and the Compensation Committee of the Board, Effective September 30, 2025Huize Holding Limited announced that Mr. Aaron Xiaolei Hou has tendered his resignation from his position as an independent director from the board of directors (the “Board”) and as a member of each of the nominating and corporate governance committee, the audit committee and the compensation committee of the Board, effective September 30, 2025, due to personal reasons. Mr. Hou's resignation did not result from any disagreement with the Company. The Board has resolved to appoint Mr. Cunjun Ma as the chairperson of the nominating and corporate governance committee of the Board, replacing Mr. Hou’s role.
分析記事 • Sep 13Huize Holding Limited (NASDAQ:HUIZ) Surges 63% Yet Its Low P/E Is No Reason For ExcitementHuize Holding Limited ( NASDAQ:HUIZ ) shares have continued their recent momentum with a 63% gain in the last month...
お知らせ • Sep 02Huize Holding Limited to Report Q2, 2025 Results on Sep 12, 2025Huize Holding Limited announced that they will report Q2, 2025 results Pre-Market on Sep 12, 2025
分析記事 • Jul 15Even With A 35% Surge, Cautious Investors Are Not Rewarding Huize Holding Limited's (NASDAQ:HUIZ) Performance CompletelyDespite an already strong run, Huize Holding Limited ( NASDAQ:HUIZ ) shares have been powering on, with a gain of 35...
お知らせ • May 23Huize Holding Limited to Report Q1, 2025 Results on Jun 06, 2025Huize Holding Limited announced that they will report Q1, 2025 results Pre-Market on Jun 06, 2025
分析記事 • May 11Further Upside For Huize Holding Limited (NASDAQ:HUIZ) Shares Could Introduce Price Risks After 30% BounceHuize Holding Limited ( NASDAQ:HUIZ ) shareholders are no doubt pleased to see that the share price has bounced 30% in...
分析記事 • Mar 26Not Many Are Piling Into Huize Holding Limited (NASDAQ:HUIZ) Stock Yet As It Plummets 27%Huize Holding Limited ( NASDAQ:HUIZ ) shareholders won't be pleased to see that the share price has had a very rough...
お知らせ • Mar 10Huize Holding Limited to Report Q4, 2024 Results on Mar 24, 2025Huize Holding Limited announced that they will report Q4, 2024 results Pre-Market on Mar 24, 2025
お知らせ • Jan 16Huize Launches Customized Mid-Tier Medical Insurance Product “PrimeMed” in Partnership with CCIC and MSH CHINAHuize Holding Limited announced the launch of “PrimeMed”, a customized mid-tier medical insurance product, in collaboration with China Continent Property & Casualty Insurance Co. Ltd. (CCIC) and MSH CHINA Enterprise Services Co. Ltd. (MSH CHINA). Designed to provide scarce, high-cost medical resources such as specialized and international departments in public hospitals and designated private medical institutions, this new solution addresses the need for flexible and affordable insurance coverage. “PrimeMed”’s key features include: Flexible deductibles: three plan options are offered, including zero or low shared deductibles, making inpatient services across different medical institutions more accessible while streamlining enrollment and claims processing. Children’s coverage: allows parents to insure children under 18, expanding protection options for the family. Relative deductible scheme: enables compensation from other sources (such as public health insurance) to offset deductibles, improving the accessibility of benefits. Affordable premiums: annual premiums start from RMB958 for the primary age group, with options to add accident outpatient emergency coverage and receive family package discounts.
お知らせ • Nov 29Huize Holding Limited to Report Q3, 2024 Results on Dec 10, 2024Huize Holding Limited announced that they will report Q3, 2024 results Pre-Market on Dec 10, 2024
分析記事 • Nov 26Huize Holding Limited (NASDAQ:HUIZ) Looks Inexpensive After Falling 25% But Perhaps Not Attractive EnoughThe Huize Holding Limited ( NASDAQ:HUIZ ) share price has fared very poorly over the last month, falling by a...
お知らせ • Nov 01Huize Holding Limited, Annual General Meeting, Nov 29, 2024Huize Holding Limited, Annual General Meeting, Nov 29, 2024, at 10:00 China Standard Time. Location: 3904-3905, tower 6, the gateway, harbour city, tsim sha tsui hong kong, China
分析記事 • Sep 18Huize Holding Limited's (NASDAQ:HUIZ) 30% Dip In Price Shows Sentiment Is Matching RevenuesUnfortunately for some shareholders, the Huize Holding Limited ( NASDAQ:HUIZ ) share price has dived 30% in the last...
お知らせ • Sep 17Huize Holding Limited to Report Q2, 2024 Results on Sep 25, 2024Huize Holding Limited announced that they will report Q2, 2024 results Pre-Market on Sep 25, 2024
お知らせ • Jun 22Huize Holding Limited (NasdaqGM:HUIZ) agreed to acquire an unknown minority stake in Global Care Consulting Joint Stock Company from VinaCapital Ventures.Huize Holding Limited (NasdaqGM:HUIZ) agreed to acquire an unknown minority stake in Global Care Consulting Joint Stock Company from VinaCapital Ventures on June 20, 2024. Pursuant to purchase of existing shares and subscription of new shares, VinaCapital Ventures will receive partial consideration of newly issued class A common shares of Huize Holding Limited out of which 50% will be subject to a one-year lock-up period.
分析記事 • Jun 13Huize Holding Limited (NASDAQ:HUIZ) Surges 25% Yet Its Low P/S Is No Reason For ExcitementDespite an already strong run, Huize Holding Limited ( NASDAQ:HUIZ ) shares have been powering on, with a gain of 25...
お知らせ • May 18Huize Holding Limited to Report Q1, 2024 Results on May 23, 2024Huize Holding Limited announced that they will report Q1, 2024 results After-Market on May 23, 2024
お知らせ • Apr 20Huize Holding Limited Partners with PICC Life Insurance Company Limited to Launch "I Wu You - Low-Threshold Edition" - A Customized Critical Illness Insurance ProductHuize Holding Limited announced that it has partnered with PICC Life Insurance Company Limited to launch "i Wu You - Low-Threshold Edition", the latest customized critical illness insurance product in the "i Wu You" series that offers a personalized solution with a relaxed health declaration process to customers. 'i Wu You - Low- Threshold Edition' differentiates itself with three key product offerings: i) flexible coverage for 28 severe and three mild illnesses, with a maximum of one claim for severe illnesses and three claims for mild illnesses and an option of lifetime coverage or up to age 70; ii) a relaxed health declaration process that is open to customers with a history of pre-existing conditions, hospitalization, and premium loading; and iii) a low eligibility threshold open to customers aged 30 to 65. The product also offers customers additional value-added services including multi-disciplinary consultation.
お知らせ • Apr 17Huize Holding Limited Partners with Aviva-COFCO Life Insurance Co., Ltd. to Launch Fu Man Jia, a Customized Participating Whole Life Insurance ProductHuize Holding Limited announced that it has partnered with Aviva-COFCO Life Insurance Co. Ltd. to launch “Fu Man Jia”, a customized participating whole life insurance product. Fu Man Jia” stands out with three key features: i) stable value growth with long-term potential returns: a guaranteed return on a compound basis of 2.5% with additional non-guaranteed annual dividend; ii) low threshold with high dividend flexibility: policy available to customers from 30 days after birth to 70 years old, with options in receiving dividend payout, including cash payment, dividends on deposit, premium reduction, or purchasing paid-up additional insurance; and iii) enhanced flexibility with premium payment terms of single upfront payment or annual payments ranging from 3 years to 15 years.
お知らせ • Apr 16Huize Partners with Ruihua Health Assurance Corporation to Launch "Darwin Critical Care No.9" - A Customized Critical Illness Insurance ProductHuize Holding Limited announced that it has partnered with Ruihua Health Assurance Corporation to launch “Darwin Critical Care No.9”, the latest customized critical illness insurance product in the “Darwin Critical Care” series, which was first launched in 2018.
Reported Earnings • Mar 24Full year 2023 earnings released: EPS: CN¥1.40 (vs CN¥0.61 loss in FY 2022)Full year 2023 results: EPS: CN¥1.40 (up from CN¥0.61 loss in FY 2022). Revenue: CN¥1.20b (up 3.3% from FY 2022). Net income: CN¥70.2m (up CN¥101.4m from FY 2022). Profit margin: 5.9% (up from net loss in FY 2022). The move to profitability was primarily driven by lower expenses. Revenue is forecast to stay flat during the next 2 years compared to a 5.9% growth forecast for the Insurance industry in the US. Over the last 3 years on average, earnings per share has increased by 65% per year but the company’s share price has fallen by 58% per year, which means it is significantly lagging earnings.
お知らせ • Mar 22Huize Holding Limited (NasdaqGM:HUIZ) announces an Equity Buyback for $5 million worth of its shares.Huize Holding Limited (NasdaqGM:HUIZ) announces a share repurchase program. Under the program, the company will repurchase up to $5 million worth of its class A common shares in the form of American depositary shares. The company expects to fund repurchases made under this program from its cash balance and cash generated from operations. The repurchase program will be valid for 12 months.
お知らせ • Mar 08Huize Holding Limited to Report Q4, 2023 Results on Mar 20, 2024Huize Holding Limited announced that they will report Q4, 2023 results Pre-Market on Mar 20, 2024
Board Change • Mar 02Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. Independent Director Aaron Xiaolei Hou was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.
分析記事 • Feb 06Market Cool On Huize Holding Limited's (NASDAQ:HUIZ) Revenues Pushing Shares 26% LowerUnfortunately for some shareholders, the Huize Holding Limited ( NASDAQ:HUIZ ) share price has dived 26% in the last...
New Risk • Jan 21New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of American stocks, typically moving 11% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 2.9% per year for the foreseeable future. Minor Risks Share price has been volatile over the past 3 months (11% average weekly change). Market cap is less than US$100m (US$35.8m market cap).
お知らせ • Dec 15Huize Holding Limited Partners with PICC Life Insurance Company Limited to Launch "Darwin Critical Care No.8 - Advanced" - Customized Critical Illness Insurance ProductHuize Holding Limited announced that it has partnered with PICC Life Insurance Company Limited ("PICC Life") to launch "Darwin Critical Care No.8 - Advanced", the latest customized critical illness insurance product in the "Darwin Critical Care" series, first launched in 2018. 'Darwin Critical Care No. 8 - Advanced' provides extensive coverage for 120 critical, 20 moderate, and 40 mild illnesses, and is distinguished by five key product highlights: i) cost-effectiveness, with a minimum annual premium of RMB 65, providing a maximum of 1 claim for severe illnesses, 3 claims for moderate illnesses, and 5 claims for mild illnesses; ii) rapid protection, with first claim available in as few as 90 days; i) low eligibility threshold, open to a large variety of occupation including electricians, firefighters, sailors, riot police, etc. and a lenient health condition screening for consumers with specified pre-existing conditions; iv) a premium waiver benefit for mild-to-moderate illness; and v) optional benefits including supplemental medical care benefits and benefits of up to 120% of the original sum assured for severe malignant tumors and a premium waiver benefit for critical illness. The product also offers customers value-added services such as unlimited online doctor consultations.
Reported Earnings • Nov 23Third quarter 2023 earnings released: EPS: CN¥0.41 (vs CN¥0.21 loss in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.41 (up from CN¥0.21 loss in 3Q 2022). Revenue: CN¥292.4m (down 17% from 3Q 2022). Net income: CN¥20.2m (up CN¥30.7m from 3Q 2022). Profit margin: 6.9% (up from net loss in 3Q 2022). The move to profitability was driven by lower expenses. Revenue is forecast to grow 16% p.a. on average during the next 2 years, compared to a 6.5% growth forecast for the Insurance industry in the US. Over the last 3 years on average, earnings per share has increased by 36% per year but the company’s share price has fallen by 50% per year, which means it is significantly lagging earnings.
Valuation Update With 7 Day Price Move • Nov 18Investor sentiment improves as stock rises 32%After last week's 32% share price gain to US$1.12, the stock trades at a trailing P/E ratio of 13.9x. Average forward P/E is 11x in the Insurance industry in the US. Total loss to shareholders of 85% over the past three years.
お知らせ • Nov 06Huize Holding Limited to Report Q3, 2023 Results on Nov 17, 2023Huize Holding Limited announced that they will report Q3, 2023 results Pre-Market on Nov 17, 2023
お知らせ • Nov 01Huize Holding Limited, Annual General Meeting, Nov 30, 2023Huize Holding Limited, Annual General Meeting, Nov 30, 2023, at 10:00 China Standard Time. Location: 76/F, The Center, 99 Queen’s Road Central, Hong Kong Special Administrative Region of the People’s Republic of China Central (Hong Kong) Hong Kong
お知らせ • Sep 28Huize Holding Limited Partners with Dingcheng Life to Launch "Xiao Tao Qi No.2" - A Customized Child Critical Illness Insurance ProductHuize Holding Limited announced that it has partnered with Dingcheng Life Insurance Company Ltd. (Dingcheng Life) to launch "Xiao Tao Qi No.2", the latest child critical illness insurance product offering in the "Xiao Tao Qi" series, which extends coverage to more illnesses and increases the hospitalization allowances for families seeking protection for their children. “Xiao Tao Qi No.2” provides extensive coverage for 190 severe, moderate and mild illnesses (compared to 183 for “Xiao Tao Qi No.1”). It is also distinguished by three key product highlights: (i) for diseases other than those specified in the policy contract as severe, moderate, and mild illnesses, ICU hospital cash benefits of RMB 1,000 per day (starting from the second day of hospitalization) for up to 90 hospitalization days per policy year and 30% of the insured amount; (ii) hospital cash benefits of RMB 300 per day for up to 60 hospitalization days per policy year and 300 hospitalization days in policy lifetime for accidents or diseases suffered by policy beneficiaries in the aftermath of a diagnosed critical illness; (iii) six optional benefits, including first-time illness care benefits, hospitalization benefits after critical illness, multiple benefits for critical illness, severely extended malignant tumors benefits, family care benefits, and death and total disability benefits. The upgraded product also provides customers with value-added services such as online doctor consultations.
Reported Earnings • Aug 17Second quarter 2023 earnings released: EPS: CN¥0.28 (vs CN¥0.77 loss in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.28 (up from CN¥0.77 loss in 2Q 2022). Revenue: CN¥368.2m (up 48% from 2Q 2022). Net income: CN¥14.1m (up CN¥53.5m from 2Q 2022). Profit margin: 3.8% (up from net loss in 2Q 2022). Revenue is forecast to grow 22% p.a. on average during the next 2 years, compared to a 5.2% growth forecast for the Insurance industry in the US. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has fallen by 49% per year, which means it is significantly lagging earnings.
Breakeven Date Change • Aug 16Forecast to breakeven in 2023The 2 analysts covering Huize Holding expect the company to break even for the first time. New consensus forecast suggests the company will make a profit of CN¥44.0m in 2023. Earnings growth of 100% is required to achieve expected profit on schedule.
お知らせ • Aug 04Huize Holding Limited to Report Q2, 2023 Results on Aug 15, 2023Huize Holding Limited announced that they will report Q2, 2023 results Pre-Market on Aug 15, 2023
分析記事 • Jul 29Potential Upside For Huize Holding Limited (NASDAQ:HUIZ) Not Without RiskHuize Holding Limited's ( NASDAQ:HUIZ ) price-to-sales (or "P/S") ratio of 0.4x may look like a pretty appealing...
Reported Earnings • Jun 02First quarter 2023 earnings released: EPS: CN¥0.35 (vs CN¥0.21 in 1Q 2022)First quarter 2023 results: EPS: CN¥0.35 (up from CN¥0.21 in 1Q 2022). Revenue: CN¥298.9m (flat on 1Q 2022). Net income: CN¥17.9m (up 70% from 1Q 2022). Profit margin: 6.0% (up from 3.5% in 1Q 2022). Revenue is forecast to grow 24% p.a. on average during the next 2 years, compared to a 6.1% growth forecast for the Insurance industry in the US. Over the last 3 years on average, earnings per share has fallen by 3% per year but the company’s share price has fallen by 45% per year, which means it is performing significantly worse than earnings.
お知らせ • May 20Huize Holding Limited to Report Q1, 2023 Results on May 30, 2023Huize Holding Limited announced that they will report Q1, 2023 results at 9:30 AM, US Eastern Standard Time on May 30, 2023
Reported Earnings • Mar 31Full year 2022 earnings released: CN¥0.61 loss per share (vs CN¥2.11 loss in FY 2021)Full year 2022 results: CN¥0.61 loss per share (improved from CN¥2.11 loss in FY 2021). Revenue: CN¥1.16b (down 48% from FY 2021). Net loss: CN¥31.2m (loss narrowed 71% from FY 2021). Revenue is forecast to grow 39% p.a. on average during the next 2 years, compared to a 5.5% growth forecast for the Insurance industry in the US. Over the last 3 years on average, earnings per share has fallen by 11% per year but the company’s share price has fallen by 42% per year, which means it is performing significantly worse than earnings.
お知らせ • Dec 15Huize Regains Compliance with Nasdaq Minimum Bid Price RequirementHuize Holding Limited announced that it has received a notification letter (the "Compliance Notice") from the Listing Qualifications Department of the Nasdaq Stock Market Inc. ("Nasdaq") dated December 13, 2022, informing the Company that it has regained compliance with Nasdaq Listing Rule 5450(a)(1) (the "Minimum Bid Price Requirement"). As previously announced, the Company was notified by Nasdaq on October 12, 2022, that the Company was not in compliance with the Minimum Bid Price Requirement, as the closing bid price of the Company's American depositary shares ("ADSs") was below $1.00 per share for 30 consecutive business days. On December 13, 2022, Nasdaq confirmed in the Compliance Notice that the closing bid price of the Company's ADSs has been at $1.00 per share or greater for 11 consecutive business days from November 28, 2022, through December 12, 2022. According to the Compliance Notice, the Company has regained compliance with Listing Rule 5450(a)(1), and the matter is closed.
Breakeven Date Change • Nov 19Forecast breakeven date pushed back to 2023The 2 analysts covering Huize Holding previously expected the company to break even in 2022. New consensus forecast suggests losses will reduce by 94% to 2022. The company is expected to make a profit of CN¥21.9m in 2023. Average annual earnings growth of 124% is required to achieve expected profit on schedule.
Reported Earnings • Nov 18Third quarter 2022 earnings released: CN¥0.21 loss per share (vs CN¥1.55 loss in 3Q 2021)Third quarter 2022 results: CN¥0.21 loss per share (improved from CN¥1.55 loss in 3Q 2021). Revenue: CN¥351.8m (up 12% from 3Q 2021). Net loss: CN¥10.5m (loss narrowed 87% from 3Q 2021). Revenue is forecast to grow 29% p.a. on average during the next 3 years, compared to a 5.4% growth forecast for the Insurance industry in the US.
お知らせ • Nov 12Huize Holding Limited Provides Earnings Guidance for the Final Quarter of 2022Huize Holding Limited provided earnings guidance for the final quarter of 2022. Based on the Company’s preliminary assessment of the current market conditions, the Company expects to achieve profitability in the final quarter of 2022. This forecast reflects the Company’s current and preliminary views on the market and operational conditions, which are subject to change as a result of various market uncertainties.
お知らせ • Nov 04Huize Holding Limited to Report Q3, 2022 Results on Nov 11, 2022Huize Holding Limited announced that they will report Q3, 2022 results at 4:00 PM, US Eastern Standard Time on Nov 11, 2022
お知らせ • Nov 03Huize Holding Limited, Annual General Meeting, Dec 01, 2022Huize Holding Limited, Annual General Meeting, Dec 01, 2022, at 10:00 China Standard Time. Location: 49/F, Building T1, Qianhai Financial Centre Qianhai,Shenzhen-Hong Kong Cooperation Zone, Shenzhen 518000 Shenzhen China
お知らせ • Oct 22Huize Partners with Guolian Life Insurance to Launch “Darwin Critical Care No. 7”Huize Holding Limited announced that it has partnered with Guolian Life Insurance Co. Ltd. (“Guolian Life Insurance”) to launch “Darwin Critical Care No. 7”, the latest critical illness insurance product offering in the Darwin Critical Care series, which offers additional benefits for severe/mild malignant tumors and carcinoma in situ, as well as ICU hospitalization benefits covering major diseases outside the list of severe, moderate and mild illnesses. “Darwin Critical Care No.7” policyholders will also be able to take advantage of Huize’s proprietary “Xiao Ma Claim” services. “Darwin Critical Care No. 7” is distinguished by five key product highlights: (i) extensive coverage for 110 critical, 35 moderate, and 40 mild illnesses, with a maximum of 8 claims; (ii) two additional benefits, with one for severe malignant tumors of up to 120% of the insured amount and another for mild malignant tumors and carcinoma in situ of up to 30% of the insured amount; (iii) additional ICU hospitalization benefits of up to 30% of the insured amount for 7 consecutive days of ICU hospitalization caused by major diseases other than those specified in the policy contract, such as shock, cardiac arrest and hypertensive crisis; (iv) cost-effective upgrade options for critical illness protections, such as the optional extension of coverage up to age 70; (v) other optional benefits including death and total disability benefits, family care benefits for critical illnesses before the age of 60, supplemental coverage for major illnesses such as specific cardiovascular diseases, malignant tumors or carcinoma in situ before the age of 60, and additional ICU hospitalization benefits.
Seeking Alpha • Oct 14Huize gets non-compliance notice from NasdaqHuize (NASDAQ:HUIZ) said Friday it received a notice from Nasdaq indicating that it was not in compliance with the minimum bid price rule for continued listing. HUIZ has 180 days, or till Apr. 10, to regain compliance. If HUIZ does not regain compliance by then, it may be eligible for an additional 180-day compliance period if it meets other continued listing rules. In this case, HUIZ should provide written notice of its intention to cure the deficiency during the second compliance period, including by effecting a reverse stock split. HUIZ is at high risk of performing badly, according to SA Quant rating system, as it has decelerating momentum and inferior profitability vs. other financial stocks.
Reported Earnings • Sep 26Second quarter 2022 earnings releasedSecond quarter 2022 results: Revenue: CN¥248.2m (up 14% from 2Q 2021). Net loss: CN¥39.4m (loss narrowed 49% from 2Q 2021). Revenue is forecast to grow 27% p.a. on average during the next 3 years, compared to a 5.2% growth forecast for the Insurance industry in the US.
Seeking Alpha • Sep 23Huize Holding GAAP EPS of -$0.01, revenue of $37.06MHuize Holding press release (NASDAQ:HUIZ): Q2 GAAP EPS of -$0.01. Revenue of $37.06M (+13.5% Y/Y). Based on the company’s preliminary assessment of the current market conditions, the Company currently expects to achieve quarterly profitability in the second half of 2022.
お知らせ • Sep 10Huize Holding Limited to Report Q2, 2022 Results on Sep 23, 2022Huize Holding Limited announced that they will report Q2, 2022 results at 9:30 AM, US Eastern Standard Time on Sep 23, 2022
Reported Earnings • Jun 29First quarter 2022 earnings released: EPS: CN¥0.21 (vs CN¥0.56 in 1Q 2021)First quarter 2022 results: EPS: CN¥0.21 (down from CN¥0.56 in 1Q 2021). Revenue: CN¥299.5m (down 59% from 1Q 2021). Net income: CN¥10.6m (down 63% from 1Q 2021). Profit margin: 3.5% (down from 3.9% in 1Q 2021). The decrease in margin was driven by lower revenue. Over the next year, revenue is forecast to grow 24% while the industry in the US is not expected to grow.
お知らせ • Jun 25Huize Holding Limited Provide Profit Guidance Second Half of 2022Huize Holding Limited provided profit guidance second half of 2022. Based on the Company's preliminary assessment of the current market conditions, the Company currently expects toachieve quarterly profitability in the second half of 2022. This forecast reflects the Company's current and preliminary views on the market and operational conditions, which are subject to change as a result of various market uncertainties.
お知らせ • Jun 21Huize Holding Limited to Report Q1, 2022 Results on Jun 24, 2022Huize Holding Limited announced that they will report Q1, 2022 results Pre-Market on Jun 24, 2022
Reported Earnings • May 02Full year 2021 earnings: EPS and revenues exceed analyst expectationsFull year 2021 results: CN¥2.11 loss per share (down from CN¥0.45 loss in FY 2020). Revenue: CN¥2.25b (up 84% from FY 2020). Net loss: CN¥107.7m (loss widened 401% from FY 2020). Revenue exceeded analyst estimates by 15%. Earnings per share (EPS) also surpassed analyst estimates by 72%. Over the next year, revenue is forecast to grow 24% while the insurance industry in the US is not expected to grow.
Breakeven Date Change • Apr 27Forecast breakeven date pushed back to 2023The 2 analysts covering Huize Holding previously expected the company to break even in 2022. New consensus forecast suggests losses will reduce by 56% to 2022. The company is expected to make a profit of CN¥38.8m in 2023. Average annual earnings growth of 99% is required to achieve expected profit on schedule.
お知らせ • Dec 18Huize Holding Limited (NasdaqGM:HUIZ) entered into an agreement to acquire Shanghai Senhao Insurance Agency Co., Ltd. for CNY 29.8 million.Huize Holding Limited (NasdaqGM:HUIZ) entered into an agreement to acquire Shanghai Senhao Insurance Agency Co., Ltd. for CNY 29.8 million on December 17, 2021. Transaction is subject to the satisfaction of customary conditions precedent. Transaction is expected to complete in the first quarter of 2022.
分析記事 • Dec 09Broker Revenue Forecasts For Huize Holding Limited (NASDAQ:HUIZ) Are Surging HigherShareholders in Huize Holding Limited ( NASDAQ:HUIZ ) may be thrilled to learn that the analysts have just delivered a...
Reported Earnings • Dec 04Third quarter 2021 earnings: EPS in line with analyst expectations despite revenue beatThird quarter 2021 results: CN¥1.55 loss per share (down from CN¥0.29 profit in 3Q 2020). Revenue: CN¥315.1m (down 9.6% from 3Q 2020). Net loss: CN¥78.9m (down CN¥93.6m from profit in 3Q 2020). Revenue exceeded analyst estimates by 2.5%. Over the next year, revenue is forecast to grow 55% compared to a 1.0% decline forecast for the industry in the US.
Seeking Alpha • Dec 03Huize's Q3-21 Results, And Its Risks And OpportunitiesHUIZ released Q3-21 financial results, Gross Written Premiums (“GWP”) +24% YoY, and First-year premiums (“FYP”) +42.7% YoY. HUIZ is traded at 1.1x P/B and 0.27x P/S, clearly undervalued, but hard to predict its timing to recover. HUIZ could fare well for the industry regulatory changes as a 15-year veteran but still face the market "fear" along with other China stocks. HUIZ's market position seems more opportunities than risks.
お知らせ • Dec 03Huize Holding Limited Provides Earnings Outlook for the Full Year of 2021Huize Holding Limited provided earnings outlook for the full year of 2021. For the period the company expect total operating revenue to be in the range of RMB 1.9 billion to RMB 2.0 billion, or approximately USD 295 to USD 310 million, an increase of approximately 56% to 64% year-over-year.
Seeking Alpha • Nov 24Huize Grows Top Line But With Higher CostsChina-based Huize Holding went public in the U.S. in May 2020, raising $55 million. The firm provides an online marketplace for Chinese consumers to purchase various insurance and savings products. While HUIZ has grown revenue, operating costs have also risen and the firm faces ongoing regulatory risks domestically and in the U.S. At around $1.68 per share, my outlook on the stock is Neutral until these risks are materially reduced.
Seeking Alpha • Sep 17Huize: Fundamentals Remain Intact, Undervalued With The Recent Sell-OffHUIZ's fundamentals remain intact, H1 2021 total gross written premium was RMB2.06, +72.7% YoY, and total operating revenue was RMB950 million, which nearly doubled YoY. HUIZ is traded at its all-time low of $2.18 vs. $13.85 52-week-high. This is about 0.5x TTM P/S, vs. SelectQuote's 2.5x TTM P/S. HUIZ is undervalued, especially with the recent selloff.
Breakeven Date Change • Sep 15Forecast to breakeven in 2021The 4 analysts covering Huize Holding expect the company to break even for the first time. New consensus forecast suggests the company will make a profit of CN¥23.0m in 2021. Earnings growth of 160% is required to achieve expected profit on schedule.
Breakeven Date Change • Sep 12Forecast to breakeven in 2021The 4 analysts covering Huize Holding expect the company to break even for the first time. New consensus forecast suggests the company will make a profit of CN¥77.0m in 2021. Earnings growth of 133% is required to achieve expected profit on schedule.
Reported Earnings • Sep 12Second quarter 2021 earnings released: CN¥1.51 loss per share (vs CN¥0.073 loss in 2Q 2020)The company reported a poor second quarter result with increased losses, weaker revenues and weaker control over costs. Second quarter 2021 results: Revenue: CN¥218.6m (down 7.0% from 2Q 2020). Net loss: CN¥77.2m (loss widened CN¥73.5m from 2Q 2020).
Valuation Update With 7 Day Price Move • Sep 10Investor sentiment deteriorated over the past weekAfter last week's 20% share price decline to US$2.38, the stock trades at a forward P/E ratio of 6x. Average forward P/E is 12x in the Insurance industry in the US. Total loss to shareholders of 72% over the past year.
Seeking Alpha • Aug 31Huize Vs. SelectQuote: Which Is A Better InvestmentHuize and SelectQuote are online B2B2C insurance brokerages. Although it is significantly oversold lately, Huize continues to operate superior to its peers. Huize has bigger market share in a faster growing market.
お知らせ • Aug 25Huize Holding Limited entered into a binding memorandum of agreement to acquire an unknown majority stake in Hubei Shengs Life & General Insurance Agency Co., Ltd.Huize Holding Limited entered into a binding memorandum of agreement to acquire an unknown majority stake in Hubei Shengs Life & General Insurance Agency Co., Ltd on August 24, 2021. Huize Holding Limited (NasdaqGM:HUIZ) will enter into definitive agreements with Shengs Life & General and its shareholders in connection with the transaction. Following the completion of the transaction, Shengs Life & General will be accounted for as a consolidated subsidiary of the Huize Holding Limited. Transaction is subject to completion of customary conditions. Huize Holding Limited expects the transaction to completed by the end of 2021
Seeking Alpha • Aug 19Huize: The Dip Of The DecadeHuize is down 83% from its all-time high, and 78% from its IPO. The company has a huge upside because of its low valuation. Despite the massive selloff, Huize continues to grow & make its business consumer-friendly. It's highly likely that Huize will be the best-performing China stock of the 2020s.
Valuation Update With 7 Day Price Move • Aug 13Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to CN¥2.70, the stock trades at a forward P/E ratio of 6x. Average forward P/E is 12x in the Insurance industry in the US. Total loss to shareholders of 69% over the past year.
Reported Earnings • May 22First quarter 2021 earnings released: EPS CN¥0.56 (vs CN¥0.21 loss in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: CN¥735.0m (up 196% from 1Q 2020). Net income: CN¥28.5m (up CN¥34.0m from 1Q 2020). Profit margin: 3.9% (up from net loss in 1Q 2020). The move to profitability was driven by higher revenue.
お知らせ • May 19Huize Holding Limited Provides Earnings Guidance for the Second Quarter of 2021Huize Holding Limited provided earnings guidance for the second quarter of 2021. The company currently expects total operating revenue for the second quarter of 2021 to be in the range of RMB 230 million to RMB 250 million. This forecast reflects the company’s current and preliminary views on the market and operational conditions, which are subject to change as a result of various market uncertainties, including those related to the ongoing COVID-19 pandemic globally.
Reported Earnings • Mar 13Full year 2020 earnings releasedThe company reported a solid full year result with reduced losses, improved revenues and improved control over expenses. Full year 2020 results: Revenue: CN¥1.22b (up 23% from FY 2019). Net loss: CN¥23.6m (loss narrowed 6.9% from FY 2019).
お知らせ • Mar 05Huize Holding Limited to Report Q4, 2020 Results on Mar 10, 2021Huize Holding Limited announced that they will report Q4, 2020 results Pre-Market on Mar 10, 2021
Is New 90 Day High Low • Feb 11New 90-day high: US$8.15The company is up 11% from its price of US$7.37 on 12 November 2020. The American market is up 16% over the last 90 days, indicating the company underperformed over that time. However, its price trend is similar to the Insurance industry, which is also up 11% over the same period.
お知らせ • Feb 10Huize Holding Limited Announces Changes to Board of DirectorsHuize Holding Limited announced the appointment of Mr. Aaron Xiaolei Hou to the company's board of directors, effective on February 12, 2021. Mr. Hou will also serve as a member of the audit committee of the board, a member of the compensation committee of the board, and a member of the nominating and corporate governance committee of the board. Mr. Li Jiang, the Company’s Chief Operating Officer, will step down from his position as a director of the Company, effective from the same date, following which the majority of the company's board will be comprised of independent directors. Mr. Jiang will continue to serve as the Chief Operating Officer of the Company. Mr. Hou has nearly 20 years of risk management and capital markets experience. He founded China Springs Capital Co. Ltd. in October 2016, and currently serves as its Chief Executive Officer and Chief Investment Officer.
お知らせ • Jan 28Huize Holding Limited Announces Earnings Guidance for the Fourth Quarter of 2020Huize Holding Limited announced earnings guidance for the fourth quarter of 2020. Total operating revenue for the fourth quarter of 2020 is expected to be at least RMB 380 million, representing a record quarterly high and a year-over-year growth of 47.1%, exceeding the Company's previous guidance of RMB 330 million to RMB 350 million.
Is New 90 Day High Low • Jan 20New 90-day low: US$6.60The company is down 10.0% from its price of US$7.33 on 21 October 2020. The American market is up 13% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Insurance industry, which is up 16% over the same period.
Is New 90 Day High Low • Dec 24New 90-day low: US$6.95The company is down 12% from its price of US$7.93 on 24 September 2020. The American market is up 18% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Insurance industry, which is up 19% over the same period.
分析記事 • Dec 08What Type Of Shareholders Own The Most Number of Huize Holding Limited (NASDAQ:HUIZ) Shares?Every investor in Huize Holding Limited ( NASDAQ:HUIZ ) should be aware of the most powerful shareholder groups...
Reported Earnings • Nov 22Third quarter 2020 earnings released: EPS CN¥0.29The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2020 results: Revenue: CN¥348.5m (up 23% from 3Q 2019). Net income: CN¥14.7m (up CN¥14.4m from 3Q 2019). Profit margin: 4.2% (up from 0.1% in 3Q 2019). The increase in margin was driven by higher revenue.
お知らせ • Nov 10Huize Holding Limited to Report Q3, 2020 Results on Nov 19, 2020Huize Holding Limited announced that they will report Q3, 2020 results at 9:00 AM, China Standard Time on Nov 19, 2020
お知らせ • Nov 03Huize Holding Limited, Annual General Meeting, Dec 10, 2020Huize Holding Limited, Annual General Meeting, Dec 10, 2020, at 10:00 China Standard Time. Location: 5/F, Building 3-4, Shenzhen Animation Park, Yuehai Road Nanhai Avenue, Nanshan District Shenzhen China Agenda: To discuss Company affairs with management team.
Is New 90 Day High Low • Oct 30New 90-day low: US$7.19The company is down 20% from its price of US$9.00 on 31 July 2020. The American market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Insurance industry, which is down 3.0% over the same period.
Is New 90 Day High Low • Oct 10New 90-day low: US$7.88The company is down 17% from its price of US$9.50 on 10 July 2020. The American market is up 10.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Insurance industry, which is up 7.0% over the same period.
お知らせ • Aug 13Huize Holding Limited to Report Q2, 2020 Results on Aug 20, 2020Huize Holding Limited announced that they will report Q2, 2020 results at 9:00 AM, China Standard Time on Aug 20, 2020
